换一批
换一批Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [<sup>68</sup>Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.
作者：
James P,Buteau [1]
;
Daniel,Moon [2]
;
Michael T,Fahey [3]
;
Matthew J,Roberts [4]
;
James,Thompson [5]
;
Declan G,Murphy [6]
;
Nathan,Papa [7]
;
Catherine,Mitchell [8]
;
Richard,De Abreu Lourenco [9]
;
Haryana M,Dhillon [10]
;
Veeru,Kasivisvanathan [11]
;
Roslyn J,Francis [12]
;
Phillip,Stricker [13]
;
Shihka,Agrawal [14]
;
Jonathan,O'Brien [6]
;
Aoife,McVey [6]
;
Gaurav,Sharma [15]
;
Sidney,Levy [16]
;
Narjess,Ayati [14]
;
Andrew,Nguyen [14]
;
Su-Faye,Lee [15]
;
David A,Pattison [17]
;
Dinesh,Sivaratnam [18]
;
Mark,Frydenberg [19]
;
Yang,Du [20]
;
Jehan,Titus [21]
;
Sze-Ting,Lee [22]
;
Joseph,Ischia [23]
;
Greg,Jack [23]
;
Michael S,Hofman [24]
;
Louise,Emmett [14]
作者单位：
Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: jamespatrick.buteau@unimelb.edu.au.
[1]
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Royal Melbourne Clinical School, University of Melbourne, Melbourne, Australia.
[2]
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
[3]
Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Brisbane, Australia.
[4]
Department of Urology, St. George Hospital, Sydney, Australia.
[5]
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
[6]
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
[7]
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
[8]
Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia.
[9]
Psycho-Oncology Cooperative Research Group, Centre for Medical Psychology & Evidence-based Decision-making, University of Sydney, Camperdown, Australia.
[10]
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Division of Surgery and Interventional Science, University College London, London, UK.
[11]
Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, Australia.
[12]
St. Vincent's Prostate Cancer Research Centre, Garvan Institute, UNSW Sydney, Sydney, Australia; Department of Urology, St. Vincent's Hospital, Sydney, Australia.
[13]
Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
[14]
Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia.
[15]
Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia; Department of Nuclear Medicine, Cabrini Health, Melbourne, Australia.
[16]
Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, Australia; School of Medicine, University of Queensland, Brisbane, Australia.
[17]
Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia; Department of Nuclear Medicine, Cabrini Health, Melbourne, Australia.
[18]
Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Cabrini Research, Cabrini Health, Melbourne, Australia.
[19]
Department of Nuclear Medicine, PET and Bone Densitometry, South Australia Medical Imaging, Royal Adelaide Hospital, Adelaide, Australia.
[20]
Department of Urology, Royal Adelaide Hospital, Adelaide, Australia.
[21]
Department of Medicine, University of Melbourne, Melbourne, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
[22]
University of Melbourne Department of Surgery, Austin Health, Melbourne, Australia.
[23]
Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
[24]
主题词
人类(Humans);男(雄)性(Male);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);依地酸(Edetic Acid);镓放射性同位素(Gallium Radioisotopes);多中心研究(主题)(Multicenter Studies as Topic);寡肽类(Oligopeptides);前列腺肿瘤(Prostatic Neoplasms);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1016/j.euo.2023.11.008
PMID
38061976
发布时间
2024-07-23
- 浏览0
European urology oncology
European urology oncology
2024年7卷3期
544-552页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
